These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35016115)

  • 1. Design, synthesis and biological evaluation of simplified analogues of MraY inhibitory natural product with rigid scaffold.
    Okamoto K; Ishikawa A; Okawa R; Yamamoto K; Sato T; Yokota SI; Chiba K; Ichikawa S
    Bioorg Med Chem; 2022 Feb; 55():116556. PubMed ID: 35016115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and conformation-activity relationship analysis of LNA/BNA-type 5'-O-aminoribosyluridine as MraY inhibitors.
    Kusaka S; Yamamoto K; Shinohara M; Minato Y; Ichikawa S
    Bioorg Med Chem; 2022 Jul; 65():116744. PubMed ID: 35500521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caprazamycins: Biosynthesis and structure activity relationship studies.
    Wiker F; Hauck N; Grond S; Gust B
    Int J Med Microbiol; 2019 Jul; 309(5):319-324. PubMed ID: 31138496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analogues of Muraymycin Nucleoside Antibiotics with Epimeric Uridine-Derived Core Structures.
    Spork AP; Koppermann S; Schier Née Wohnig S; Linder R; Ducho C
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30400295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caprazamycins: Promising lead structures acting on a novel antibacterial target MraY.
    Patel B; Ryan P; Makwana V; Zunk M; Rudrawar S; Grant G
    Eur J Med Chem; 2019 Jun; 171():462-474. PubMed ID: 30933853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of nucleoside antibacterial natural product antibiotics.
    Bugg TDH; Kerr RV
    J Antibiot (Tokyo); 2019 Dec; 72(12):865-876. PubMed ID: 31471595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoribosylated Analogues of Muraymycin Nucleoside Antibiotics.
    Wiegmann D; Koppermann S; Ducho C
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30486316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Biological Evaluation of Muraymycin Analogues Active against Anti-Drug-Resistant Bacteria.
    Tanino T; Ichikawa S; Al-Dabbagh B; Bouhss A; Oyama H; Matsuda A
    ACS Med Chem Lett; 2010 Sep; 1(6):258-62. PubMed ID: 24900205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muraymycin nucleoside-peptide antibiotics: uridine-derived natural products as lead structures for the development of novel antibacterial agents.
    Wiegmann D; Koppermann S; Wirth M; Niro G; Leyerer K; Ducho C
    Beilstein J Org Chem; 2016; 12():769-795. PubMed ID: 27340469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simplified Novel Muraymycin Analogues; using a Serine Template Strategy for Linking Key Pharmacophores.
    Patel B; Kerr RV; Malde AK; Zunk M; Bugg TDH; Grant G; Rudrawar S
    ChemMedChem; 2020 Aug; 15(15):1429-1438. PubMed ID: 32476294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muraymycin Nucleoside Antibiotics: Structure-Activity Relationship for Variations in the Nucleoside Unit.
    Heib A; Niro G; Weck SC; Koppermann S; Ducho C
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31861655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospho-MurNAc-pentapeptide translocase (MraY) as a target for antibacterial agents and antibacterial proteins.
    Bugg TD; Lloyd AJ; Roper DI
    Infect Disord Drug Targets; 2006 Jun; 6(2):85-106. PubMed ID: 16789873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a natural product optimization strategy for inhibitors against MraY, a promising antibacterial target.
    Yamamoto K; Sato T; Hao A; Asao K; Kaguchi R; Kusaka S; Ruddarraju RR; Kazamori D; Seo K; Takahashi S; Horiuchi M; Yokota SI; Lee SY; Ichikawa S
    Nat Commun; 2024 Jun; 15(1):5085. PubMed ID: 38877016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Medicinal Chemistry of Muraymycins, Nucleoside Antibiotics.
    Katsuyama A; Ichikawa S
    Chem Pharm Bull (Tokyo); 2018; 66(2):123-131. PubMed ID: 29386462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum to "Design, synthesis and biological evaluation of simplified analogues of MraY inhibitory natural product with rigid scaffold" Bioorganic & Medicinal Chemistry 55 (2021) 116556.
    Okamoto K; Ishikawa A; Okawa R; Yamamoto K; Sato T; Yokota SI; Chiba K; Ichikawa S
    Bioorg Med Chem; 2022 May; 61():116689. PubMed ID: 35272912
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis of macrocyclic nucleoside antibacterials and their interactions with MraY.
    Nakaya T; Yabe M; Mashalidis EH; Sato T; Yamamoto K; Hikiji Y; Katsuyama A; Shinohara M; Minato Y; Takahashi S; Horiuchi M; Yokota SI; Lee SY; Ichikawa S
    Nat Commun; 2022 Dec; 13(1):7575. PubMed ID: 36539416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of sub-micromolar inhibitors of MraY by exploring the region originally occupied by the diazepanone ring in the liposidomycin structure.
    Dini C; Didier-Laurent S; Drochon N; Feteanu S; Guillot JC; Monti F; Uridat E; Zhang J; Aszodi J
    Bioorg Med Chem Lett; 2002 Apr; 12(8):1209-13. PubMed ID: 11934590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of 5'-C-piperidinyl-5'-O-aminoribosyluridines as potential antibacterial agents.
    Nakaya T; Matsuda A; Ichikawa S
    Org Biomol Chem; 2015 Jul; 13(28):7720-35. PubMed ID: 26090936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function-Oriented Synthesis: How to Design Simplified Analogues of Antibacterial Nucleoside Natural Products?
    Ichikawa S
    Chem Rec; 2016 Jun; 16(3):1106-15. PubMed ID: 27027613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical logic of MraY inhibition by antibacterial nucleoside natural products.
    Mashalidis EH; Kaeser B; Terasawa Y; Katsuyama A; Kwon DY; Lee K; Hong J; Ichikawa S; Lee SY
    Nat Commun; 2019 Jul; 10(1):2917. PubMed ID: 31266949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.